ly 97241 has been researched along with e 4031 in 3 studies
Studies (ly 97241) | Trials (ly 97241) | Recent Studies (post-2010) (ly 97241) | Studies (e 4031) | Trials (e 4031) | Recent Studies (post-2010) (e 4031) |
---|---|---|---|---|---|
11 | 0 | 1 | 356 | 1 | 86 |
Protein | Taxonomy | ly 97241 (IC50) | e 4031 (IC50) |
---|---|---|---|
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.0381 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gessner, G; Heinemann, SH | 1 |
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
Sen, S; Sinha, N | 1 |
3 other study(ies) available for ly 97241 and e 4031
Article | Year |
---|---|
Inhibition of hEAG1 and hERG1 potassium channels by clofilium and its tertiary analogue LY97241.
Topics: Animals; Cell Line; Cricetinae; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; Humans; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quaternary Ammonium Compounds; Xenopus | 2003 |
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |